Plasma Adiponectin Concentrations and Risk of Incident Breast Cancer | Zendy

Shelley S. Tworoger | Zendy; A. Heather Eliassen | Zendy; Theodoros Kelesidis | Zendy; Graham A. Colditz | Zendy; Walter C. Willett | Zendy; Christos S. Mantzoros | Zendy; Susan E. Hankinson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Plasma Adiponectin Concentrations and Risk of Incident Breast Cancer

Author(s) -

Shelley S. Tworoger,

A. Heather Eliassen,

Theodoros Kelesidis,

Graham A. Colditz,

Walter C. Willett,

Christos S. Mantzoros,

Susan E. Hankinson

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2006-1975

Subject(s) - medicine , breast cancer , adiponectin , body mass index , prospective cohort study , nurses' health study , menarche , confidence interval , obstetrics , endocrinology , cancer , gynecology , obesity , insulin resistance

Previous retrospective case-control studies suggest that adiponectin, an obesity-related hormone, is inversely associated with breast cancer risk, particularly in postmenopausal women; however, no prospective studies exist. Therefore, we conducted a prospective case-control study nested within the Nurses' Health Study (NHS) and NHSII cohorts examining the association between plasma adiponectin concentrations and breast cancer risk.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research